ArtivionAORT +0.36%81 PEG Ratio is 1.69 as of Jun. 30, 2026, which is 90% below its 10-year median of 16.80. GuruFocus rates AORT with a GF Score™ of 81/100 and a GF Value™ of $28.37 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 207 Medical Devices & Instruments companies, Artivion ranks better than 56.04% on this metric.
PE Ratio without NRI / 5-Year EBITDA Growth Rate*
PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, Artivion's PE Ratio without NRI is 34.57. Artivion's 5-Year EBITDA growth rate is 20.40%. Therefore, Artivion's PEG Ratio for today is 1.69.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Artivion's PEG Ratio or its related term are showing as below:
AORT'
s PEG Ratio Range Over the Past 10 Years
Min: 1.61 Med: 16.8 Max: 1586.11
Current: 1.69
During the past 13 years, Artivion's highest PEG Ratio was 1586.11. The lowest was 1.61. And the median was 16.80.
AORT's PEG Ratio is ranked better than 56.04% of 207
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs AORT: 1.69
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Artivion (NYSE:AORT) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Artivion PEG Ratio Related Terms
Artivion PEG Ratio Historical Data
* Premium members only.
The historical data trend for Artivion's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Artivion's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Artivion PEG Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Artivion's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Artivion's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Artivion (AORT) has a PEG Ratio of 1.69 as of Jun. 30, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Artivion and its competitors. This is 90% below median its historical median of 16.80. Over the past decade, Artivion's PEG Ratio has ranged from 1.61 to 1,586.11. According to the industry distribution chart, Artivion ranks #91 out of 207 companies in the Medical Devices & Instruments industry, placing it in the top 44%.
Is Artivion's PEG Ratio too high?
Artivion's current PEG Ratio of 1.69 is 90% below median its 10-year median of 16.80. Over the past 10 years, this metric has ranged from a low of 1.61 to a high of 1,586.11. The Medical Devices & Instruments industry median PEG Ratio is 2.05. Artivion's value of 1.69 is 17.6% below this industry median. Based on the distribution chart, Artivion ranks #91 out of 207 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Artivion has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Artivion's PEG Ratio compare to LMRI and AVNS?
According to the Medical Devices & Instruments industry distribution chart, Artivion ranks #91 out of 207 companies for PEG Ratio. This puts Artivion in the upper half of its industry. The industry median PEG Ratio is 2.05. Artivion's value of 1.69 is 17.6% below this benchmark. Historically, Artivion's own PEG Ratio has ranged from 1.61 to 1,586.11 over the past decade. While the company's 10-year median is 16.80 vs. the industry median of 2.05, Artivion has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Devices & Instruments company?
The median PEG Ratio among Medical Devices & Instruments companies is 2.05, based on 207 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Artivion's current PEG Ratio of 1.69 is 17.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Artivion and its competitors. For the Medical Devices & Instruments industry, the median PEG Ratio is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artivion's current PEG Ratio is 1.69, which is 90% below median its own 10-year median of 16.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artivion stock overvalued right now?
Based on GuruFocus' analysis, Artivion (AORT) is currently considered Modestly Undervalued. The stock's GF Value™ is $28.37, compared to a current price of $22.47 — trading 20.8% below its estimated fair value. The current PEG Ratio is 1.69, which is 90% below median its 10-year median of 16.80 and 17.6% below the Medical Devices & Instruments industry median of 2.05. Artivion's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Artivion (AORT), the current PEG Ratio is 1.69 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Artivion (AORT) Overvalued in 2026?
Based on GuruFocus' analysis, Artivion stock appears to be undervalued.
The current stock price of $22.47 is trading 20.8% below its estimated GF Value™ of $28.37.
GuruFocus considers Artivion to be Modestly Undervalued.
Key valuation signals for AORT:
PEG Ratio: 1.69 (90% below median its 10-year median of 16.80)
GF Value™: $28.37 vs. price of $22.47 (20.8% below fair value)
Industry Position: 17.6% below the Medical Devices & Instruments median (#91 of 207)
No single metric tells the full story. See the AORT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
81GF Score
Get the complete analysis for AORT
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AORT has been successfully added to your 
